Skip to main content
. 2022 Apr 25;10(3):e00177-22. doi: 10.1128/spectrum.00177-22

FIG 5.

FIG 5

FMT treatment alleviates the activation of astrocytes and microglia in the spinal cord after injury. (A) A spinal cord section with outlined gray matter area and a squared inset of ventral horn. (B) Representative images of immunofluorescent staining for Iba-1 (a marker of microglia) and GFAP (a marker of astrocytes) detection in the ventral horn of the injured spinal cord on day 28 (Scale bar = 50 μm). (C) Quantification of the Iba-1-positive area in the ventral horn of spinal cord on day 28 post-SCI (n = 4). (D) Quantification of the GFAP-positive area in the ventral horn of spinal cord on day 28 post-SCI (n = 4). *, P < 0.05 compared to the SCI group; **, P < 0.01 compared to the SCI group.